Plain-language summary: Hemostemix will officially apply for ethics approval to begin a new clinical trial testing its ACP-01 stem-cell therapy in people with severe chest pain (angina) who no longer ...

This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular senescence, and tissue degeneration. By dissecting B-cell dysfunction, ...

Immune checkpoint inhibitors (ICI) have had a dramatic effect on cancer outcomes with their use increasing as indications expand. Despite impressive efficacy across a range of tumour types, their role ...